Aberdeen Asset Management (LON:ADN) Rating Reaffirmed
Research analysts at Goldman Sachs now has a GBX 345.00 Estimated Target Price on Aberdeen Asset Management (LON:ADN). Goldman Sachs and their recent Estimated Target Price may mean a potential upside of 17.99% from the company’s price per share. The rating has been announced in analysts report on Thursday, 10 December.
From a total of 17 analysts covering Aberdeen Asset Management PLC (LON:ADN) stock, 3 rate it a ”Buy”, 5 a “Sell”, and 10 a ”Hold”. This means that 17% of the ratings are positive. The highest target price is GBX 430 while the lowest target price is GBX 260. The mean of all analyst targets is GBX 328.82 with a 19.27% above today’s (GBX 293.9) stock price. Aberdeen Asset Management PLC was the topic of 49 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Liberum Capital maintained shares on December 8 with “Buy” rating. BNP Paribas maintained shares with “Underperform” rating and GBX 260 target share price in a report from a December 1. Charles Stanley maintained ADN stock in a recent report from December 4 with “Buy” rating. Jefferies maintained the rating on December 1. Jefferies has a “Hold” rating and a GBX 286 price target on shares. Finally, Beaufort Securities maintained the stock with “Buy” rating in a report issued on a December 1.
Approximately 1.55M shares of stock traded hands. Aberdeen Asset Management plc (LON:ADN) has declined 32.78% since May 13, 2015 and is downtrending. It has underperformed by 30.84% the S&P500.
Aberdeen Asset Management PLC is United Kingdom asset management company. The company has a market cap of 3.90 billion GBP. The Firm manages assets for both institutional and retail clients. It has 13.49 P/E ratio. The firm invests across the four main asset classes of equity, fixed income, property and alternative investment strategies.